Logo image of CTHR

CHARLES & COLVARD LTD (CTHR) Stock Fundamental Analysis

NASDAQ:CTHR - Nasdaq - US1597652056 - Common Stock - Currency: USD

1.21  -0.08 (-6.2%)

After market: 1.33 +0.12 (+9.92%)

Fundamental Rating

2

CTHR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 49 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of CTHR is average, but there are quite some concerns on its profitability. CTHR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CTHR had negative earnings in the past year.
In the past year CTHR has reported a negative cash flow from operations.
In multiple years CTHR reported negative net income over the last 5 years.
Of the past 5 years CTHR 4 years had a positive operating cash flow.
CTHR Yearly Net Income VS EBIT VS OCF VS FCFCTHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

1.2 Ratios

CTHR has a worse Return On Assets (-44.65%) than 93.75% of its industry peers.
CTHR has a Return On Equity of -59.15%. This is in the lower half of the industry: CTHR underperforms 79.17% of its industry peers.
Industry RankSector Rank
ROA -44.65%
ROE -59.15%
ROIC N/A
ROA(3y)-5.63%
ROA(5y)-5.01%
ROE(3y)-7.41%
ROE(5y)-6.44%
ROIC(3y)N/A
ROIC(5y)N/A
CTHR Yearly ROA, ROE, ROICCTHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

The Gross Margin of CTHR (29.03%) is worse than 81.25% of its industry peers.
In the last couple of years the Gross Margin of CTHR has declined.
CTHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.92%
GM growth 5Y-3.46%
CTHR Yearly Profit, Operating, Gross MarginsCTHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

4

2. Health

2.1 Basic Checks

CTHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CTHR has less shares outstanding
The number of shares outstanding for CTHR has been increased compared to 5 years ago.
There is no outstanding debt for CTHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CTHR Yearly Shares OutstandingCTHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CTHR Yearly Total Debt VS Total AssetsCTHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -1.64, we must say that CTHR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CTHR (-1.64) is worse than 85.42% of its industry peers.
CTHR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
CTHR has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. CTHR outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -1.64
ROIC/WACCN/A
WACC9.68%
CTHR Yearly LT Debt VS Equity VS FCFCTHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

CTHR has a Current Ratio of 2.47. This indicates that CTHR is financially healthy and has no problem in meeting its short term obligations.
CTHR has a Current ratio of 2.47. This is in the better half of the industry: CTHR outperforms 66.67% of its industry peers.
CTHR has a Quick Ratio of 1.26. This is a normal value and indicates that CTHR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.26, CTHR is in the better half of the industry, outperforming 60.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.26
CTHR Yearly Current Assets VS Current LiabilitesCTHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

CTHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.95%, which is quite impressive.
The Revenue for CTHR has decreased by -29.69% in the past year. This is quite bad
Measured over the past years, CTHR shows a small growth in Revenue. The Revenue has been growing by 2.07% on average per year.
EPS 1Y (TTM)32.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)-29.69%
Revenue growth 3Y0.86%
Revenue growth 5Y2.07%
Sales Q2Q%-20.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y94.81%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTHR Yearly Revenue VS EstimatesCTHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CTHR Yearly EPS VS EstimatesCTHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2 3 4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CTHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CTHR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTHR Price Earnings VS Forward Price EarningsCTHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTHR Per share dataCTHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHARLES & COLVARD LTD

NASDAQ:CTHR (2/28/2025, 8:00:00 PM)

After market: 1.33 +0.12 (+9.92%)

1.21

-0.08 (-6.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-11 2025-02-11
Earnings (Next)04-30 2025-04-30
Inst Owners7.03%
Inst Owner Change-6.99%
Ins Owners21.21%
Ins Owner Change0%
Market Cap3.67M
Analysts82.86
Price TargetN/A
Short Float %3.91%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-2.39
FCFYN/A
OCF(TTM)-2.01
OCFYN/A
SpS7.82
BVpS10.21
TBVpS10.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.65%
ROE -59.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.03%
FCFM N/A
ROA(3y)-5.63%
ROA(5y)-5.01%
ROE(3y)-7.41%
ROE(5y)-6.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.92%
GM growth 5Y-3.46%
F-Score2
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 159.57%
Cap/Sales 4.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 1.26
Altman-Z -1.64
F-Score2
WACC9.68%
ROIC/WACCN/A
Cap/Depr(3y)202.46%
Cap/Depr(5y)161.04%
Cap/Sales(3y)3.05%
Cap/Sales(5y)2.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y94.81%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.69%
Revenue growth 3Y0.86%
Revenue growth 5Y2.07%
Sales Q2Q%-20.78%
Revenue Next Year10.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-182.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-579.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-309.87%
OCF growth 3YN/A
OCF growth 5YN/A